TAC1 and disease of the tendon: While inflammatory pathways such as local production of substance P are thought to contribute to the changes observed in tendinopathy [3,12], a number of structural changes occur in tendinopathy which a superficially delivered NSAID may be unable to counter, such as collagen disorganization and disarray, increased glycosaminoglycan, and neurovascular proliferation [7].